Genser SG et al. Sex for crack as an AIDS risk behaviour: an ethnographic study, VIII International AIDS Conference, Amsterdam, abstract WeC 1032, 1992.

Gossop, M. Living with Drugs. Ashgate Publishing Ltd. 1996.

Kim AA et al. Increased risk of HIV and sexually transmitted disease transmission among gay or bisexual men who use Viagra, San Francisco 2000-2001, AIDS 16(10): 1425-1428, 2002

Lindsay MK et al. Crack cocaine: a risk factor for HIV, Obstet Gynecol 80(6): 981-984, 1992.

Murji, K. Policing Drugs. Ashgate Publishing Ltd. 1998.

Parsons et al. Over a decade of syringe exchange; results from 1997 UK survey. The Centre for research on drugs and health behaviour. www.harmreduction.org/research 1997

Patterson TP et al. HIV-positive methamphetamine users: Social and behavioural outcomes of binge use, XIV International AIDS Conference, Barcelona, abstract E11681, 2002.

Piaseczna MA et al. Predictors of HIV seroconversion among young men who have sex with men in Canada, XIV International AIDS Conference, Barcelona, abstract MoPeC3450, 2002.

Rhodes T et al. Drug injecting, rapid HIV spread and the risk environment: implications for assessment and response. AIDS 13 Supp A S259-270, 1999.

Riley SC et al. Patterns of recreational drug use at dance events in Edinburgh, Scotland, Addiction 96(7): 1035-1047, 2001.

Riehman K. Injecting drug use and AIDS in developing countries: determinants and issues for policy consideration. World Bank (available from http://www.worldbank.org/aids-econ/confront/backgrnd/riehman/index.htm)

Schoenfisch S et al. Risk of HIV infection and behavioural changes associated with crack cocaine use in prenatal patients, IX International AIDS Conference, Berlin, abstract PoC 15-2920, 1993.

Sherr L et al. Viagra use and sexual risk among HIV-positive and HIV-negative gay men in London. XIII International AIDS Conference, Durban, abstract WePpD1409, 2000.

Stark, C et al (eds). Illegal Drug use in the United Kingdom; Prevention, treatment and enforcement. Ashgate. 1999.

Sterk C. Cocaine and seropositivity, Lancet 8593: 1052-1053, 1988.